阿波利波蛋白A-I血管基因疗法可以减少静脉移植动脉样硬化
Lianxiang Bi1, Bradley K Wacker1, Kaushik Komandur1
1Department of Medicine, University of Washington, 1959 NE Pacific St., Seattle, WA 98195, USA.
Molecular therapy. Methods & clinical development
|September 11, 2023
概括
使用依赖助手的腺病毒表达阿波利波蛋白AI (HDAdApoAI) 的基因治疗有效地减少了静脉移植中的脂质和巨细胞积累,为预防静脉移植动脉样硬化和失败提供了有前途的新方法.
科学领域:
- 心血管生物学 心血管生物学
- 基因治疗 基因治疗
- 血管外科 血管外科
背景情况:
- 冠状动脉旁路移植通常由于动脉样硬化而失败,其特征是脂质和巨细胞的积累.
- 目前的治疗方法,如他类药物,在治疗静脉移植动脉样硬化方面有效性有限.
研究的目的:
- 研究助手依赖性腺病毒表达阿波利波蛋白AI (HDAdApoAI) 的潜力,以减少静脉移植中的脂质和巨细胞积累.
- 评估*in vivo*基因治疗在预防静脉移植失败方面的疗效.
主要方法:
- 脂肪养的子接受了外静脉到动脉间接移植.
- 手术后四周,移植物用HDAdApoAI或对照物 (HDAdNull) 进行了转化.
- 12周后分析了静脉移植的胆固醇,内脏脂质和巨细胞含量 (CD68表达).
主要成果:
- 在所有接受治疗的移植中检测到HDAd基因组.
- 与对照组相比,HDAdApoAI移植的mRNA表达显著更高.
- 在静脉移植中,HDAdApoAI治疗导致总胆固醇,内脏脂质含量和CD68表达的降低.
结论:
- 在活体中使用HDAdApoAI进行基因治疗,成功地在静脉移植内皮中实现了持续的阿波利波蛋白AI表达.
- 这种方法有效地减少了动脉样硬化的关键标志物,包括胆固醇,内脏脂质和巨细胞积累.
- 针对阿波利波蛋白AI的血管基因疗法在预防静脉移植失败方面具有重大前景.
相关概念视频
01:26Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
01:30Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
01:25Hemodialysis I: Introduction
51
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
51
01:23Atherosclerosis IV: Nursing Management
21
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
21